Isomorphic Labs 正在洽谈筹集约50亿美元新资金，以支持其利用人工智能进行药物发现的努力，消息人士称。
Inc.’s Isomorphic Labs is in talks to raise roughly $5 billion in new funds to support its efforts to use artificial intelligence for drug discovery, according to people familiar with the matter.
该轮融资将使从 Alphabet 的 Google DeepMind 派生的 Isomorphic 估值约为500亿美元，消息人士表示，他们在匿名的前提下透露此信息，且该信息尚未公开。融资尚未完成，细节可能会变更，消息人士说。
The round would value Isomorphic, which spun out of Alphabet’s Google DeepMind, at about $50 billion, said the people, who spoke on condition of anonymity as the information is not public. The financing hasn’t closed and details could change, the people said.
Isomorphic 未回应置评请求。彭博新闻此前报道，该公司正处于与估值高达500亿美元的新一轮融资的早期谈判中。
Isomorphic did not respond to a request for comment. Bloomberg News previously reported the company was in early talks for a new round at a valuation as high as $50 billion.
伦敦总部的 Isomorphic 于2021年从 DeepMind 分拆成立，目标是基于实验室突破的 AlphaFold 蛋白质折叠模型进行进一步发展。它与一系列试图将最新 AI 进展应用于医学的企业竞争，其中包括今年发布生命科学研究模型的 OpenAI。
London-based Isomorphic was formed in 2021 out of DeepMind with the goal of building upon the lab’s breakthrough AlphaFold protein-folding model. It competes with an array of businesses trying to apply the latest AI advances to medicine. That includes OpenAI, which this year released a model for life sciences research.
在周一于伦敦举行的彭博科技大会上，Isomorphic 总裁 Max Jaderberg 说，公司利用 AI 进行更快、更高效药物发现的努力仍处于临床前试验阶段。他表示，Isomorphic 仍处于“公司第一轮”阶段。
Speaking at the Bloomberg Tech conference in London on Monday, Isomorphic president Max Jaderberg said the company’s efforts to use AI for faster and more efficient drug discovery are still in preclinical trials. Isomorphic is in its “first innings” as a company, he said.
今年一月，Isomorphic 首席执行官 Demis Hassabis 表示，公司预计将在2026年底前进入首个临床试验。
In January, Isomorphic’s Chief Executive Officer Demis Hassabis had said it expected to move into its first clinical trials by the end of 2026.
Isomorphic 在5月完成了一轮21亿美元融资，由 Thrive Capital 主导，Alphabet 及其他投资者参与。
Isomorphic raised $2.1 billion in a funding round in May led by Thrive Capital, with participation from Alphabet and other investors.